VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
LGND
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
LGNDLigand Pharmaceuticals Incorporated
$302.96$6.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksLGNDQuarterly Balance Sheet

Ligand Pharmaceuticals Incorporated (LGND) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Ligand Pharmaceuticals Incorporated (LGND) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

LGND Balance Sheet

Quarterly statement

LGND Balance Sheet

Ligand Pharmaceuticals Incorporated (LGND) balance sheet — 30-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets1.46B865.41M832.27M753.92M352.94M309.32M331.56M309.39M312.26M368.91M237.43M253.99M276.71M328.19M263.6M220.43M243.78M276.07M464.75M432.08M
Cash & Short-Term Investments1.36B779.4M733.52M664.52M255.3M208.9M256.17M219.64M226.93M310.59M170.31M190.5M219.04M282.67M211.87M121.41M147.94M204M341.11M323.21M
Cash Only1.01B115.08M174.93M139.38M67.67M47.99M72.31M63.62M18.14M50.09M22.95M19.27M28.45M282.67M45.01M4.12M5.28M14.99M19.52M23.43M
Short-Term Investments351.06M664.33M558.59M525.15M187.63M160.91M183.86M156.02M208.79M260.5M147.35M171.23M190.6M0166.86M117.29M142.66M189.01M321.59M299.78M
Accounts Receivable69.92M54.8M61.05M58.1M42.12M42.83M42.45M42.13M37.48M28.43M39.31M36M27.99M29.19M35.04M65.95M63.27M41.8M91.65M70.71M
Days Sales Outstanding89.1100.7991.8539.9281.1584.6590.8870.6872.2299.51123.2989.5798.6865.72171.77100.3895.37164.45103.0594.76
Inventory10.26M13.27M9.13M11.9M12.89M11.81M14.11M13.44M14.47M21.34M23.97M25.39M26.91M14.01M13.29M22.33M24.77M25.61M27.33M33M
Days Inventory Outstanding333.1485.61-37.2245.94386.65240.62446.77102.76-106.31186.251.36K690.31.12K330.5775.81153.08185.47506.98231.54293.14
Other Current Assets19.17M17.95M28.58M19.4M40.04M42.97M16.9M30.87M27.26M7.31M2.66M2.1M2.77M2.33M2.27M10.75M7.8M4.66M4.67M5.16M
Total Non-Current Assets728.76M666.69M728.37M722.85M595.66M596.12M610.22M645.48M554.15M544.96M549.79M515.23M481.39M482.88M499.07M830.17M832.5M829.12M832.84M841.57M
Property, Plant & Equipment6.44M10.28M10.79M11.07M11.62M10.49M24.81M25.19M25.46M24.38M25.06M25.98M26.54M15.61M27.49M46.55M39.74M55.99M32.6M48.45M
Fixed Asset Turnover7.62x4.91x5.46x10.17x4.31x2.57x1.71x2.05x1.67x1.25x1.10x1.25x1.25x2.04x0.73x1.37x1.05x0.82x1.79x1.44x
Goodwill101.54M101.54M101.54M101.54M101.54M101.54M105.25M105.25M105.25M105.25M103.37M103.77M105.67M439.59M105.67M698.23M709.57M181.21M105.67M190.18M
Intangible Assets209.24M410.88M422.31M233.53M250.13M258.39M266.65M274.9M283.16M291.42M299.61M321.44M336.16M10.43M352.64M10.19M10.27M549.83M386.8M573.12M
Long-Term Investments156.87M132.81M183.58M42M204.46M199.23M195.93M212.4M93.66M112.68M111.61M47.08M003M00000
Other Non-Current Assets217.54M2.71M1.79M325.18M27.07M25.92M17.51M27.65M46.43M11.22M9.92M8.43M4.5M16.38M1.74M39.7M37.27M6.44M272.03M3.1M
Total Assets2.19B1.53B1.56B1.48B948.6M905.43M941.77M954.87M866.4M913.87M787.22M769.23M758.11M811.08M762.67M1.05B1.08B1.11B1.3B1.27B
Asset Turnover0.03x0.03x0.04x0.10x0.05x0.05x0.05x0.06x0.05x0.04x0.04x0.04x0.03x0.06x0.03x0.06x0.05x0.03x0.06x0.05x
Asset Growth %130.43%69.21%65.71%54.66%9.49%-0.92%19.63%24.13%14.29%12.67%3.22%-26.78%-29.56%-26.61%-41.22%-17.51%-14.33%-14.67%-4.75%2.1%
Total Current Liabilities46.74M40.67M37.45M30.54M64.73M58.68M37.11M24.77M18.57M17.82M16.78M15.73M29.39M98.93M98.81M135.24M167.85M42.58M41.66M36.3M
Accounts Payable9.4M5.26M3.24M27.76M8.58M5.37M5.23M4.69M1.79M1.89M2.43M2.48M9.58M6.13M5.31M15.89M19.15M6.97M8.4M7.23M
Days Payables Outstanding207.67184.38-54.8767.36218.3498.36160.9623.88-10.9417.76135.51159.15428.47138.5245.11113.8996.16147.2460.0298.49
Short-Term Debt0001.09M00000000076.79M76.69M76.6M114.97M000
Deferred Revenue (Current)621K621K621K135K732K722K1.9M1.77M1.82M1.85M1.84M621K621K257K976K9.55M10.58M10.5M654K12.01M
Other Current Liabilities544K4.13M6.81M-821K39.67M28.88M-3.2M3.96M2.83M2.03M4.94M3.81M2.79M13.31M6.26M14.88M12.14M5.14M22.57M7.26M
Current Ratio31.18x21.28x22.23x24.69x5.45x5.27x8.93x12.49x16.82x20.70x14.15x16.15x9.42x3.32x2.67x1.63x1.45x6.48x11.15x11.90x
Quick Ratio30.96x20.95x21.98x24.30x5.25x5.07x8.55x11.95x16.04x19.51x12.72x14.54x8.50x3.18x2.53x1.46x1.30x5.88x10.50x11.00x
Cash Conversion Cycle214.52402.02109.5118.5249.46226.91376.69149.56-23.152681.35K620.72785.68257.76202.47139.57184.68524.19274.58289.42
Total Non-Current Liabilities1.17B494.12M505.98M496.06M55.34M51.22M74.22M88.92M72.64M89.53M69.52M85.6M63.83M65.83M66.37M99.07M106.07M269.41M434.77M425.29M
Long-Term Debt1.13B446.9M446.19M445.49M0000000000000176.54M320.72M316.89M
Capital Lease Obligations3.78M3.99M4.2M4.42M4.63M3.56M5.82M6.27M6.42M5.19M5.75M5.83M10.99M11.18M10.34M34.89M27.09M16.76M2.26M11.47M
Deferred Tax Liabilities21.65M22.61M52.61M22.67M32.25M29.38M32.52M46.4M30.13M50.61M31.62M32.59M27.66M30.01M30.61M29.83M42.67M39.48M30.86M63.03M
Other Non-Current Liabilities19.6M20.61M2.97M23.48M18.47M18.27M35.88M33.74M18.59M16.97M17M47.19M25.17M24.64M25.38M28.8M28.89M36.64M80.94M33.91M
Total Liabilities1.22B534.78M543.42M526.6M120.08M109.9M111.33M113.69M91.21M107.35M86.3M101.33M93.21M164.76M165.18M234.31M273.92M311.99M476.43M461.59M
Total Debt1.13B451.98M451.49M451M5.74M4.45M7.11M7.36M7.58M6.19M6.17M6.33M11.67M88.68M87.75M113.89M144.61M195.2M324.39M330.58M
Net Debt124.75M336.9M276.56M311.62M-61.93M-43.54M-65.2M-56.26M-10.56M-43.9M-16.79M-12.95M-16.77M-193.99M42.74M109.77M139.33M180.21M304.86M307.15M
Debt / Equity1.17x0.45x0.44x0.47x0.01x0.01x0.01x0.01x0.01x0.01x0.01x0.01x0.02x0.14x0.15x0.14x0.18x0.25x0.40x0.41x
Debt / EBITDA67.80x17.67x15.22x7.16x0.34x--0.61x-0.53x1.11x0.54x1.55x3.73x3.76x4.41x6.65x12.37x12.63x11.67x
Net Debt / EBITDA7.48x13.17x9.32x4.94x-3.65x---4.64x--3.74x-3.02x-1.11x-2.23x-8.16x1.83x4.25x6.41x11.42x11.87x10.85x
Interest Coverage36.79x-12.89x31.81x-10.73x-56.88x-43.39x-7.55x-50.57x805.59x131.51x-12143.00x12.17x59.19x234.04x38.21x20.77x-10.59x-0.57x2.68x
Total Equity967.52M997.32M1.02B950.17M828.53M795.53M830.44M841.18M775.2M806.52M700.91M667.9M664.89M646.32M597.49M816.3M802.37M793.19M821.16M812.07M
Equity Growth %16.78%25.37%22.49%12.96%6.88%-1.36%18.48%25.94%16.59%24.79%17.31%-18.18%-17.13%-18.52%-27.24%0.52%2.02%6.35%15.73%16.37%
Book Value per Share44.3150.1648.1247.1141.5841.4543.7745.6743.0044.5139.6538.4337.5035.9635.3847.6547.5747.1549.0747.37
Total Shareholders' Equity967.52M997.32M1.02B950.17M828.53M795.53M830.44M841.18M775.2M806.52M700.91M667.9M664.89M646.32M597.49M816.3M802.37M793.19M821.16M812.07M
Common Stock20K20K20K20K20K20K20K19K19K18K18K18K17K17K17K17K17K17K17K17K
Retained Earnings583.25M594.74M608.09M578.22M461.38M456.53M498.98M530.07M537.24M589.15M503.02M484.83M495.1M492.81M450.86M468.35M467.94M468.84M449.09M454.51M
Treasury Stock00000000000000000000
Accumulated OCI4.48M5.39M8.46M9.32M8.49M-1.56M-5.94M1.75M-935K-910K-817K-944K-967K-935K-984K-1.06M-1.07M-1.03M-917K-875K
Minority Interest00000000000000000000